G6 Supplies has introduced the outcomes of an antimicrobial efficacy take a look at on a prototype of its proprietary graphene-based air air purifier, performed by a US-based microbiological laboratory of The Intertek Group. The take a look at reportedly confirmed that the focus of pathogenic microorganisms current within the testing chamber was decreased by 99.9% over the period of the experiment.
Two totally different pathogens have been randomly chosen to be examined underneath every experiment, which have been the E. coli micro organism and the Phi-X174 bacteriophage. The period of the take a look at was set to 2 hours.
The Firm started growing the proprietary know-how contained within the graphene-based air purification prototype in early 2020. The primary profitable implementation of G6’s distinctive method to permit for the incorporation of graphene oxide in an air filtration system for the aim of bettering its antimicrobial efficiency was previously announced in April 2020. Since then, the Firm has filed a provisional patent utility that summarizes its proprietary method.
Daniel Stolyarov, President & CEO of G6 Supplies, stated: “We’re excited to obtain these constructive outcomes from a revered impartial laboratory. Now, we’re desirous to take the subsequent steps towards the commercialization of this know-how, together with acquiring all vital licenses, authorities approvals and accreditations to allow us to convey the product to the market. At the moment, we’re finalizing the plans to fabricate the graphene-enhanced air air purifier and are making ready its preliminary advertising and marketing marketing campaign, extra details about which will likely be introduced sooner or later”. “I’m very happy with our crew and recognize the onerous work and dedication that was required from every of them with the intention to attain this level. We’re additionally proud to develop a product that’s able to making our houses and workplaces safer in these tough instances,” added Mr. Stolyarov.